Clinical Trials Directory

Trials / Completed

CompletedNCT02037958

Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic Cholecystectomy

The Laryngeal Mask Airway Supreme (TM) is an Effective Alternative to Laryngoscope-guided Tracheal Intubation for Patients Undergoing Elective Laparoscopic Cholecystectomy-- A Prospective Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Changi General Hospital · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

We hypothesise that the use of the LMA-Supreme provides greater ease of insertion and reduced haemodynamic variability during insertion compared to the tracheal tube, whilst still maintaining a patent airway to facilitate elective laparoscopic cholecystectomy in selected patients.

Detailed description

The Laryngeal Mask Airway Supreme(LMA-S) has been used successfully to maintain a patent airway for laparoscopic surgery. Our study compares the use of LMA-S with that of the tracheal tube (ETT) with respect to the ease of insertion and potential haemodynamic disturbance during insertion.

Conditions

Interventions

TypeNameDescription
DEVICELaryngeal Mask Airway-SupremePatients who receive the LMA-S
DEVICEEndotracheal TubePatients who receive endotracheal intubation

Timeline

Start date
2011-04-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2014-01-16
Last updated
2014-01-16

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT02037958. Inclusion in this directory is not an endorsement.